Review article

You have full text access to this OnlineOpen article

Risk of ovarian failure and fertility preserving methods in girls and adolescents with a malignant disease

  1. KT Schmidt1,
  2. EC Larsen1,
  3. CY Andersen2,
  4. AN Andersen1

Article first published online: 29 OCT 2009

DOI: 10.1111/j.1471-0528.2009.02408.x

Issue

BJOG: An International Journal of Obstetrics & Gynaecology

BJOG: An International Journal of Obstetrics & Gynaecology

Special Issue: The gynaecological and reproductive health problems of puberty and adolescence

Volume 117, Issue 2, pages 163–174, January 2010

Additional Information

How to Cite

Schmidt, K., Larsen, E., Andersen, C. and Andersen, A. (2010), Risk of ovarian failure and fertility preserving methods in girls and adolescents with a malignant disease. BJOG: An International Journal of Obstetrics & Gynaecology, 117: 163–174. doi: 10.1111/j.1471-0528.2009.02408.x

Author Information

  1. 1

    The Fertility Clinic

  2. 2

    Laboratory of Reproductive Biology, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark

*Dr KT Schmidt, The Fertility Clinic, Section 4071, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark. Email kirsten.tryde.schmidt@rh.regionh.dk

Publication History

  1. Issue published online: 9 DEC 2009
  2. Article first published online: 29 OCT 2009
  3. Accepted 10 September 2009. Published online 29 October 2009.

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (148K)

References

  • 1
    Gatta G, Capocaccia R, Coleman MP, Ries LAG, Berrino F. Childhood cancer survival in Europe and the United States. Cancer 2002;95:1767–72.
    Direct Link:
  • 2
    Edgar AB, Morris EMM, Kelnar CJK, Wallace WHB. Long-term follow-up of survivors of childhood cancer. Endocr Dev 2009;15:159–80.
  • 3
    Mertens AC, Yasui Y, Neglia JP, Potter JD, Nesbit ME Jr, Ruccione K, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: The Childhood Cancer Survivor Study. J Clin Oncol 2001;19:3163–72.
  • 4
    Meistrich ML, Shetty G. Hormonal suppression for fertility preservation in males and females. Reproduction 2008;136:691–701.
  • 5
    Porcu E, Bazzocchi A, Notarangelo L, Paradisi R, Landolfo C, Venturoli S. Human oocyte cryopreservation in infertility and oncology. Curr Opin Endocrinol Diabetes Obes 2008;15:529–35.
  • 6
    Practice Committee of American Society for Reproductive Medicine; Practice Committee of Society for Assisted Reproductive Technology. Ovarian tissue and oocyte cryopreservation. Fertil Steril 2008;90:S241–6.
  • 7
    von Wolff M, Donnez J, Hovatta O, Keros V, Maltaris T, Montag M, et al. Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy – a technique in ist infancy but already successful in fertility preservation. Eur J Cancer 2009;45:1547–53.
  • 8
    McCall MI, Keaty EC, Thompson JD. Conservation of ovarian tissue in the treatment of carcinoma of the cervix with radical surgery. Am J Obstet Gynecol 1958;75:590–600.
  • 9
    Gaetini A, De Simone M, Urgesi A, Levis A, Resegotti A, Ragona R, et al. Lateral high abdominal ovariopexy: an original surgical technique for protection of the ovaries during curative radiotherapy for Hodgkin’s disease. J Surg Oncol 1988;39:22–8.
    Direct Link:
  • 10
    Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N Engl J Med 2009;360:902–11.
  • 11
    Sonmezer M, Oktay K. Assisted reproduction and fertility preservation techniques in cancer patients. Curr Opin Endocrinol Diabetes Obes 2008;15:514–22.
  • 12
    Andersson RA, Wallace WHB, Baird DT. Ovarian cryopreservation for fertility preservation: indications and outcomes. Reproduction 2008;136:681–9.
  • 13
    Donnez J, Martinez-Madrid B, Jadoul P, van Langendonckt A, Demylle D, Dolmans MM. Ovarian tissue cryopreservation and transplantation: a review. Hum Reprod Update 2006;12:519–35.
  • 14
    Nicholson HS, Byrne J. Fertility and pregnancy after treatment for cancer during childhood or adolescence. Cancer 1993;71:3392–9.
    Direct Link:
  • 15
    Meirow D. Reproduction post-chemotherapy in young cancer patients. Mol Cell Endocrinol 2000;169:123–31.
  • 16
    Meirow D, Lewis H, Nugent D, Epstein M. Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool. Hum Reprod 1999;14:1903–7.
  • 17
    Wallace WHB, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 2005;62:738–44.
  • 18
    Lushbaugh CC, Casarett GW. The effects of gonadal irradiation in clinical radiation therapy: a review. Cancer 1976;37:1111–20.
    Direct Link:
  • 19
    Barrett A, Nicholls J, Gibson B. Late effects of total body irradiation. Radiother Oncol 1987;9:131–5.
  • 20
    Locatelli F, Giorgiani G, Pession A, Bozzola M. Late effects in children after bone marrow transplantation: a review. Haematologica 1993;78:319–28.
  • 21
    Salooja N, Szydlo RM, Socie G, Rio B, Chatterjee R, Ljungman P, et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet 2001;358:271–6.
  • 22
    Leiper AD, Stanhope R, Lau T, Grant DB, Blacklock H, Chessells JM, et al. The effect of total body irradiation and bone marrow transplantation during childhood and adolescence on growth and endocrine function. Br J Heamatol 1987;67:419–26.
    Direct Link:
  • 23
    Sarafoglou K, Boulad F, Gillio A, Sklar C. Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr 1997;130:210–6.
  • 24
    Teinturier C, Hartmann O, Valteau-Couanet D, Benhamou E, Bougneres PF. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant 1998;22:989–94.
  • 25
    Thibaud E, Rodriguez-Macias K, Trivin C, Esperou H, Michon J, Brauner R. Ovarian function after bone marrow transplantation during childhood. Bone Marrow Transplant 1998;21:287–90.
  • 26
    Matsumoto M, Shinohara O, Ishiguro H, Shimizu T, Hattori K, Ichikawa M, et al. Ovarian function after bone marrow transplantation performed before menarche. Arch Dis Child 1999;80:452–4.
  • 27
    Couto-Silva AC, Trivin C, Thibaud E, Esperou H, Michon J, Brauner R, et al. Factors affecting gonadal function after bone marrow transplantation during childhood. Bone Marrow Transplant 2001;28:67–75.
  • 28
    Larsen EC, Müller J, Schmiegelow K, Rechnitzer C, Andersen AN. Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab 2003;88:5307–14.
  • 29
    Chow EJ, Friedman DL, Yasui Y, Whitton JA, Stovall M, Robison LL, et al. Timing of menarche among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 2008;50:854–8.
    Direct Link:
  • 30
    Noorda EM, Somers R, van Leeuwen FE, Vulsma T, Behrendt H. Adult height and age at menarche in childhood cancer survivors. Eur J Cancer 2001;37:605–12.
  • 31
    Ogilvy-Stuart AL, Shalet SM. Effect of radiation on the human reproductive system. Environ Health Perspect 1993;101:109–16.
  • 32
    Byrne J, Fears TR, Mills JL, Zeltzer LK, Sklar C, Nicholson HS, et al. Fertility in women treated with cranial radiotherapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2004;42:589–97.
    Direct Link:
  • 33
    Shalet SM, Beardwell CG, Jones PH, Pearson D, Orrell DH. Ovarian failure following abdominal irradiation in childhood. Br J Cancer 1976;33:655–8.
  • 34
    Wallace WHB, Shalet SM, Crowne EC, Morris-Jones PH, Gattamaneni HR. Ovarian failure following abdominal irradiation in childhood: natural history and prognosis. Clin Oncol 1989;1:75–9.
  • 35
    Hamre MR, Robison LL, Nesbit ME, Sather HN, Meadows AT, Ortega JA, et al. Effects of radiation on ovarian function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group. J Clin Oncol 1987;5:1759–65.
  • 36
    Schuck A, Hamelmann V, Brämswig JH, Könemann S, Rübe C, Hesselmann S, et al. Ovarian function following pelvic irradiation in prepubertal and pubertal girls and young adult women. Strahlenther Onkol 2005;181:534–9.
  • 37
    Critchley HOD, Wallace WHB, Mamtora H, Higginson J, Anderson DC, Shalet SM. Abdominal irradiation in childhood; the potential for pregnancy. Br J Obstet Gynaecol 1992;99:392–4.
  • 38
    Larsen EC, Schmiegelow K, Rechnitzer C, Loft A, Müller J, Andersen AN. Radiotherapy at a young age reduces uterine volume of childhood cancer survivors. Acta Obstet Gynecol Scand 2004;83:96–102.
  • 39
    Wikström AM, Hovi L, Dunkel L, Saarinen-Pikhala UM. Restoration of ovarian function after chemotherapy for osteosarcoma. Arch Dis Child 2003;88:428–31.
  • 40
    Byrne J, Mulvihill JJ, Myers MH, Connelly RR, Naughton MD, Krauss MR, et al. Effects of treatment on fertility in long-term survivors of childhood or adolescent cancer. N Engl J Med 1987;317:1315–21.
  • 41
    Whitehead E, Shalet SM, Morris Jones PH, Beardwell CG, Deakin DP. Gonadal function after combination chemotherapy for Hodgkin’s disease in childhood. Arch Dis Child 1982;47:287–91.
  • 42
    Green DM, Yakar D, Brecher ML, Lindsay AN, Voorhess ML. Ovarian function in adolescent women following successful treatment for non-Hodgkin’s lymphoma. Am J Pediatr Hematol Oncol 1983;5:27–31.
  • 43
    Wallace WH, Shalet SM, Crowne EC, Morris-Jones PH, Gattamaneni HR, Price DA. Gonadal dysfunction due to cis-platinum. Med Pediatr Oncol 1989;17:409–13.
  • 44
    Clayton PE, Shalet SM, Price DA, Jones PH. Ovarian function following chemotherapy for childhood brain tumours. Med Pediatr Oncol 1989;17:92–6.
    Direct Link:
  • 45
    Mackie EJ, Radford M, Shalet SM. Gonadal function following chemotherapy for childhood Hodgkin’s disease. Med Pediatr Oncol 1996;27:74–8.
    Direct Link:
  • 46
    van den Berg H, Stuve W, Behrendt H. Treatment of Hodgkin’s disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy. Med Pediatr Oncol 1997;29:23–7.
    Direct Link:
  • 47
    Maneschi F, Fugardi MG, Corsello G, LoCurto M. Pubertal maturation in girls treated for childhood acute leukemia. Eur J Pediatr 1991;150:630–3.
  • 48
    van den Berg H, Furstner F, van den Bos C, Behrendt H. Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease. Pediatr Blood Cancer 2004;42:210–5.
    Direct Link:
  • 49
    Madanat LM, Malila N, Dyba T, Hakulinen T, Sankila R, Boice JD Jr, et al. Probability of parenthood after early onset cancer: a population-based study. Int J Cancer 2008;123:2891–8.
    Direct Link:
  • 50
    Hawkins MM. Is there evidence of a therapy-related increase in germ cell mutation among childhood cancer survivors? J Natl Cancer Inst 1991;83:1643–50.
  • 51
    Winther JF, Boice JD Jr, Frederiksen K, Bautz A, Mulvihill JJ, Stovall M, et al. Radiotherapy for childhood cancer and risk for congenital malformations in offspring: a population-based cohort study. Clin Genet 2009;75:50–6.
    Direct Link:
  • 52
    Mulvihill JJ, Myers MH, Connelly RR, Byrne J, Austin DF, Bragg K, et al. Cancer in offspring of long-term survivors of childhood and adolescent cancer. Lancet 1987;2:813–7.
  • 53
    Sankila R, Olsen JH, Anderson H, Garwicz S, Glattre E, Hertz H, et al. Risk of cancer among offspring of childhood-cancer survivors. Association of the Nordic Cancer Registries and the Nordic Society of Paediatric Heamatology and Oncology. N Engl J Med 1998;338:1339–44.
  • 54
    Blumenfeld Z, Eckman A. Preservation of fertility and ovarian function and minimization of chemotherapy-induced gonadotoxicity in young women by GnRH-a. J Natl Cancer Inst Monogr 2005;34:40–3.
  • 55
    Badawy A, Elnashar A, El-Ashry M, Shahat M. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril 2009;91:694–7.
  • 56
    Pereyra Pacheco B, Méndez Ribas JM, Milone G, Fernández I, Kvicala R, Mila T, et al. Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: a preliminary report. Gynecol Oncol 2001;81:391–7.
  • 57
    Wo JY, Viswanathan AN. Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys 2009;73:1304–12.
  • 58
    Whittingham DG. Fertilization in vitro and development to term of unfertilized mouse oocytes previously stored at –196 degrees C. J Reprod Fertil 1977;49:89–94.
  • 59
    Chen C. Pregnancy after human oocyte cryopreservation. Lancet 1986;1:884–6.
  • 60
    Cobo A, Domingo J, Pérez S, Crespo J, Remohi J, Pellicer A. Vitrification: an effective new approach to oocyte banking and preserving fertility in cancer patients. Clin Transl Oncol 2008;10:268–73.
  • 61
    Huang JY, Tulandi T, Holzer H, Tan SL, Chian RC. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril 2008;89:567–72.
  • 62
    Demirtas E, Elizur SE, Holzer H, Gidoni Y, Son WY, Chian RC, et al. Immature oocyte retrieval in the luteal phase to preserve fertility in cancer patients. Reprod Biomed Online 2008;17:520–3.
  • 63
    Andersen AN, Erb K. Register data on assisted reproductive technology (ART) in Europe including a detailed description of ART in Denmark. Int J Androl 2006;29:12–6.
    Direct Link:
  • 64
    von Wolff M, Thaler CJ, Frambach T, Zeeb C, Lawrenz B, Popovici RM, et al. Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril 2008;92:1360–5.
  • 65
    Gosden RG, Baird DT, Wade JC, Webb R. Restoration of fertility to oophorectomized sheep by ovarian autografts stored at −196°C. Hum Reprod 1994;9:597–603.
  • 66
    Oktay K, Economos K, Kan M, Rucinski J, Veeck L, Rosenwaks Z. Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm. JAMA 2001;12:1490–3.
  • 67
    Radford JA, Lieberman BA, Brison DR, Smith AR, Critchlow JD, Russell SA, et al. Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin’s lymphoma. Lancet 2001;357:1172–5.
  • 68
    Tryde Schmidt KL, Andersen CY, Starup J, Loft A, Byskov AG, Andersen AN. Orthotopic autotransplantation of cryopreserved ovarian tissue to a woman cured of cancer – follicular growth, steroid production and oocyte retrieval. Reprod Biomed Online 2004;8:448–53.
  • 69
    Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004;364:1405–10.
  • 70
    Meirow D, Levron J, Eldar-Geva T, Hardan I, Fridman E, Zalel Y, et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 2005;353:318–21.
  • 71
    Demeestere I, Simon P, Emiliani S, Delbaere A, Englert Y. Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin’s disease. Oncologist 2007;12:1437–42.
  • 72
    Andersen CY, Rosendahl M, Byskov AG, Loft A, Ottosen C, Dueholm M, et al. Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum Reprod 2008;23:2266–72.
  • 73
    Rosendahl M, Loft A, Byskov AG, Ziebe S, Schmidt KT, Andersen AN, et al. Biochemical pregnancy after fertilization of an oocyte aspirated from a heterotopic autotransplant of cryopreserved ovarian tissue: case report. Hum Reprod 2006;21:2006–9.
  • 74
    Poirot CJ, Martelli H, Genestie C, Golmard J-L, Valteau-Couanet D, Helardot P, et al. Feasibility of ovarian tissue cryopreservation for prepubertal females with cancer. Pediatr Blood Cancer 2007;49:74–8.
    Direct Link:
  • 75
    Heath JA, Stern CJ. Fertility preservation in children newly diagnosed with cancer: existing standards of practice in Australia and New Zealand. Med J Aust 2006;185:538–41.
  • 76
    Faddy MJ. Follicle dynamics during ovarian ageing. Mol Cell Endocrinol 2000;163:43–8.
  • 77
    Schmidt KL, Ernst E, Byskov AG, Nyboe Andersen A, Andersen CY. Survival of primordial follicles following prolonged transportation of ovarian tissue prior to cryopreservation. Hum Reprod 2003;18:2654–9.
  • 78
    Biggers JD, Finn CA, McLaren A. Long-term reproductive performance of female mice: effect of removing one ovary. J Reprod Fertil 1962;3:303–12.
  • 79
    Lipschutz A. Dynamics of ovarian hypertrophy under experimental conditions. Br J Exp Biol 1925;2:331–46.
  • 80
    Dailey RA, Peters JB, First NL, Chapman AB, Casida LE. Effect of unilateral ovariectomy in the Yorkshire and Poland China prepubertal gilt. J Anim Sci 1969;28:775–9.
  • 81
    Lass A. The fertility potential of women with a single ovary. Hum Reprod Update 1999;5:546–50.
  • 82
    Levitas E, Furman B, Shoham-Vardi I, Lunenfeld E, Potashnik G. Treatment outcome in women with a single ovary versus patients with two ovaries undergoing in vitro fertilization and embryo transfer (IVF/ET). Eur J Obstet Gynecol 2000;88:197–200.
  • 83
    Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update 2004;10:251–66.
  • 84
    Seshadri T, Gook D, Lade S, Spencer A, Grigg A, Tiedemann K, et al. Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin’s lymphoma and analysis of factors predictive of oocyte yield. Br J Cancer 2006;94:1007–10.
  • 85
    Meirow D, Hardan I, Dor J, Fridman E, Elizur S, Ra’anani H, et al. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod 2008;23:1007–13.
  • 86
    Osborne B, Robboy SJ. Lymphomas or leukaemia presenting as ovarian tumors an analysis of 42 cases. Cancer 1983;52:1933–43.
    Direct Link:
  • 87
    O’Brien MJ, Pendola K, Eppig JJ. A revised protocol for in vitro development of mouse oocytes from primordial follicles dramatically improves their developmental competence. Biol Reprod 2003;68:1682–6.
View Full Article (HTML) Get PDF (148K)